June 13, 2012 4:18 pm

NuvaRing® was approved by the FDA in 2001.  It is a prescription-only contraceptive vaginal ring that contains a combination of desogestrel and estrogen hormones.  Etonogestral is a synthetic form of the naturally-occuring hormone progesterone and is the active metabolite of desogestrel.  NuvaRing® is used by approximately 1.5 million women worldwide today.


The 2.5” NuvaRing® is inserted into the vaginal canal and emits estrogen and progesterone directly into the blood stream, for 21 days of protection. The user removes the ring for 7 days, during her regular menstrual cycle. The NuvaRing® birth control device has been linked to serious medical problems, including pulmonary embolism, deep vein thrombosis (DVT), heart attack, stroke, and death.


If you or a loved one were injured while using NuvaRing® birth control, call Loncar & Associates immediately.  You may be entitled to compensation for your injuries.  NuvaRing® litigation has been ongoing since 2008 and legal deadlines are rapidly approaching.  Call our office immediately at 800-285-4878, or use the contact form on the right to reach us.